Sort   by:  
 Page size 
UnknownTP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
Not available
S-EPMC7897660 | biostudies-literature
UnknownCPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML.
Not available
S-EPMC9221356 | biostudies-literature
UnknownCD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin.
Not available
S-EPMC8268215 | biostudies-literature
UnknownNew somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.
Not available
S-EPMC7445914 | biostudies-literature
UnknownTreatment free remission in chronic myeloid leukemia: Lights and shadows.
Not available
S-EPMC7520857 | biostudies-literature
UnknownPrevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study.
Not available
S-EPMC7464094 | biostudies-literature
UnknownChlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.
Not available
S-EPMC5685238 | biostudies-literature
UnknownVenetoclax: A Game Changer in the Treatment of Younger AML Patients?
Not available
S-EPMC10778458 | biostudies-literature
UnknownSpotlight on landmark oncology trials: the latest evidence and novel trial designs.
Not available
S-EPMC5454584 | biostudies-literature
UnknownGilteritinib: The Story of a Proceeding Success into Hard-to-Treat FLT3-Mutated AML Patients.
Not available
S-EPMC10253262 | biostudies-literature
Sort   by:  
 Page size